Overview
Horner syndrome is characterized by the clinical triad of miosis (pupillary constriction), ptosis (eyelid drooping), and anhidrosis (lack of sweating) on the affected side, resulting from disruption of the cervical sympathetic pathway. 46Diagnosis
Management
Special Populations
Key Recommendations
References
1 Gish P, Kim I, Kapoor R, Jones SC. Systemic Toxicity With Use of Apraclonidine Ophthalmic Drops in Pediatric Patients. JAMA ophthalmology 2025. link 2 Eldib AA, Patil P, Nischal KK, Mitchell ER, Hiasat JG, Pihlblad MS. Safety of apraclonidine eye drops in diagnosis of Horner syndrome in an outpatient pediatric ophthalmology clinic. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2021. link 3 Dafereras M, Sapouridis H, Laios K, Chrysikos D, Mavrommatis E, Troupis T. The pioneer ophthalmologist Johann Friedrich Horner (1831-1886) and the clinical anatomy of the homonymous syndrome. Acta chirurgica Belgica 2020. link 4 Folkert KN, de Beaufort H, Bauman NM. Horner Syndrome from a Pediatric Otolaryngology Perspective. The Annals of otology, rhinology, and laryngology 2020. link 5 Topcu-Yilmaz P, Kutluk S, Onder F. Horner Syndrome as a Rare Complication of Radiofrequency Tonsil Ablation. Journal of pediatric ophthalmology and strabismus 2018. link 6 Amonoo-Kuofi HS. Horner's syndrome revisited: with an update of the central pathway. Clinical anatomy (New York, N.Y.) 1999. link1098-2353(1999)12:5<345::AID-CA5>3.0.CO;2-L) 7 Gårde A. The man behind the syndrome: Friedrich Horner. Journal of the history of the neurosciences 1992. link 8 Parkinson D. Bernard, Mitchell, Horner syndrome and others?. Surgical neurology 1979. link